Objective: Changes in autism diagnostic criteria found in DSM-5 may affect autism spectrum disorder (ASD) prevalence, research findings, diagnostic processes, and eligibility for clinical and other services. Using our published, total-population Korean prevalence data, we compute DSM-5 ASD and social communication disorder (SCD) prevalence and compare them with DSM-IV pervasive developmental disorder (PDD) prevalence estimates. We also describe individuals previously diagnosed with DSM-IV PDD when diagnoses change with DSM-5 criteria. Method: The target population was all children from 7 to 12 years of age in a South Korean community (N ¼ 55,266), those in regular and special education schools, and a disability registry. We used the Autism Spectrum Screening Questionnaire for systematic, multi-informant screening. Parents of screen-positive children were offered comprehensive assessments using standardized diagnostic procedures, including the Autism Diagnostic Interview-Revised and Autism Diagnostic Observation Schedule. Best-estimate clinical diagnoses were made using DSM-IV PDD and DSM-5 ASD and SCD criteria. Results: DSM-5 ASD estimated prevalence was 2.20% (95% confidence interval ¼ 1.77-3.64). Combined DSM-5 ASD and SCD prevalence was virtually the same as DSM-IV PDD prevalence (2.64%). Most children with autistic disorder (99%), Asperger disorder (92%), and PDD-NOS (63%) met DSM-5 ASD criteria, whereas 1%, 8%, and 32%, respectively, met SCD criteria. All remaining children (2%) had other psychopathology, principally attention-deficit/hyperactivity disorder and anxiety disorder. Conclusion: Our findings suggest that most individuals with a prior DSM-IV PDD meet DSM-5 diagnostic criteria for ASD and SCD. PDD, ASD or SCD; extant diagnostic criteria identify a large, clinically meaningful group of individuals and families who require evidence-based services. J. Am. Acad. Child Adolesc. Psychiatry, 2014;53(5):500-508.
subtypes found in DSM-IV; creation of a new diagnostic category of ASD that is adapted to the individual's clinical presentation by inclusion of clinical specifiers and associated features; changing from the DSM-IV PDD 3-domain criteria that included social reciprocity, communication, and restricted and repetitive behaviors (RRB) to 2 DSM-5 ASD domain criteria composed of social communication/interaction and RRB; for DSM-5, inclusion of sensory symptoms in the RRB component of diagnostic criteria; and, for DSM-5, changing the specification of the age of onset from "age 3" to "early childhood." In addition, DSM-5 adds a new diagnostic category, "social communication disorder (SCD) ." SCD appears to include individuals who primarily have problems with the pragmatic aspects of social communication. According to DSM-5, individuals with SCD have difficulties similar to those with ASD, but these problems are restricted solely to the realm of social communication and do not include the DSM-5 RRB criteria found in ASD. 6 Apparent differences between DSM-IV PDD and DSM-5 ASD criteria have led to debates, in both the scientific and lay communities, over whether these changes in diagnostic criteria will materially affect ASD prevalence, alter the way in which individuals will be diagnosed with ASD, and, possibly, affect the eligibility of individuals for clinical and other services. Such debates are creating controversy amongst professionals, as well as confusion and anxiety for service providers, policy makers, and, most importantly, for patients and their families. 7 A number of investigators have attempted to address these important concerns by examining the reliability of the DSM-5 ASD criteria (with its sensitivity and specificity) against DSM-IV ASD criteria, primarily using clinic-based samples of individuals with ASD. Results of these studies include sensitivity ranging from 46% to 96% and specificity from 53% to 100% (some were based on different versions of draft DSM-5 criteria [8] [9] [10] [11] [12] [13] ). These studies appear to indicate that the DSM-5 ASD criteria have reasonable sensitivity and specificity against DSM-IV criteria. Nonetheless, there has been considerable debate, concern, and speculation with respect to how many individuals with DSM-IV PDD diagnoses will "lose diagnoses" with the advent of DSM-5.
To answer these questions, in this article we will directly compare DSM-IV-based and DSM-5-based ASD prevalence estimates while also determining which individuals, if any, classified as DSM-IV PDD will not meet DSM-5 ASD diagnostic criteria. We will use rigorous epidemiologic methods with a total population approach that includes both clinical and non-clinical populations of individuals with ASD, and systematic standardized screening and diagnostic assessment. Using our total-population prevalence data from a recently completed and published study from a Korean cohort, 4 we will do the following:
Compute the DSM-5-based ASD and SCD prevalence estimates among children 7 to 12 years of age Compare DSM-5 ASD and SCD prevalence estimates with DSM-IV PDD prevalence estimates Describe demographic, ASD-related clinical and other associated characteristics of those individuals with DSM-IV PDD diagnoses who were classified with ASD or SCD in DSM-5 versus those individuals with DSM-IV PDD who no longer fell into either of these DSM-5 categories.
METHOD Study Subjects
The target population (N ¼55,266) included all children born from 1993 to 1999 (7-12 years of age at screening) in a suburb of Seoul, South Korea. Total population screening was conducted with both the Parents' and Teachers' Autism Spectrum Screening Questionnaire (ASSQ), using the mandatory elementary education system and Disability Registry (DR). This total population approach allowed us to include and examine children with ASD who have used service systems, including health care and educational services (a clinical ASD population whom we labeled the "high probability group" [HPG]), as well as those children with ASD who never received any services (a nonclinical sample with ASD whom we labeled the "general population sample" [GPS]). Children were considered to be screen positive with Teacher-ASSQ scores !10 and/or Parent-ASSQ scores in the top 2nd percentile. Additional screenpositive individuals came from a random sample of 50% of children in the 3rd percentile, and 33% of students in the 4th and 5th percentiles of Parent-ASSQ scores for children in regular education schools. All children in the DR and attending special education schools with diagnoses of ASD/intellectual disability (ID) were considered screen positive. Screen-positive children were evaluated using standardized diagnostic assessments, as follows: the Autism Diagnostic Observation Schedule (ADOS), Autism Diagnostic Interview-Revised (ADI-R), cognitive tests (Korean Wechsler Intelligence Scale for Children-III and Leiter Fombonne and Leventhal) . The 2% initially discordant diagnoses were resolved in discussions among all investigators. Detailed case identification processes, validity, and reliability of best estimate diagnoses are described in our 2011 publication. 4 Using this identical study population, case identification, confirmative diagnosis, and statistical methods, we re-evaluated all of the screen-positive individuals who completed confirmative diagnostic assessment from our original study to establish diagnoses for DSM-IV PDD subtypes, DSM-5 ASD, and DSM-5 SCD, and to compute DSM-5-based ASD and SCD prevalence estimates. Of 292 cases, 60 (21%) were randomly chosen to examine diagnostic reliability for DSM-5 ASD and SCD criteria, for which each Korean team reached consensus diagnoses in all cases.
In addition to the reassessment of diagnoses for all cases, we divided the children who were ASSQ screen positive and completed diagnostic assessment in 3 groups, according to the level of agreement between DSM-IV PDD and DSM-5 ASD diagnostic criteria: 
Data Analyses
The denominator used to compute ASD prevalence was the entire target population (N ¼ 55,266) to reflect variance arising from non-participants. 4 Prevalence estimates by sex and ASD subtypes in the total population, as well as in the HPG and GPS, were computed using the SAS 9.1 Proc Frequency procedure (SAS Institute, Cary, NC). 4 Several strategies were used to adjust for missing data from screen-positive nonparticipants. Detailed methods to adjust for missing data and compute prevalence estimates are described in our 2011 publication. 4 We used c 2 statistics and analysis of variance (ANOVA) with Scheff e post hoc analyses to compare demographic, ASD-related clinical and other associated characteristics of these 3 groups. A detailed description of the participants is provided in our 2011 publication. 4 
RESULTS
Of 55,266 children 7 to 12 years of age, 36,886 children attended 33 participating elementary schools (from total 43 schools) and/or were enrolled in a DR. Parents of 23,337 children returned ASSQs (63% response). Of the 1,214 sampled screen-positive students, 869 (72%) parents consented to participate in the diagnostic stage (70% male), and 292 (34%) completed diagnostic assessment.
Prevalence Estimates of DSM-IV PDD Using DSM-IV criteria, we previously reported an estimated PDD prevalence of 2.64% (95% CI ¼ 1.91-3.37%) in a total population. We also found that the estimated DSM-IV PDD prevalence was 1.89% (1.43-2.36%) in the GPS and, total population prevalence estimate of ASD drawn from the HPG was 0.75% (0.58-0.93%), with a much higher proportion of children with ASD in the HPG. Total male and female DSM-IV PDD prevalence were 3.74% (2.57-4.90%) and 1.47% (0.60-2.37%), respectively, indicating a sex ratio of 2.5:1. In addition, we further classified DSM-IV PDD by subtypes and computed prevalence estimates for autistic disorder, Asperger disorder, and PDD-NOS, which were 1.04% (0.79-1.30%), 0.60% (0.33-0.87%), and 1.00% (0.66-1.34%), respectively (Table 1) .
Prevalence Estimates of DSM-5 ASD
The estimated total population prevalence of DSM-5 ASD was 2.20% (1.77-2.64%). This is clearly different from the DSM-IV PDD-estimated total population prevalence of 2.64%. However, examination of these data suggests that the entirety of this difference comes from those individuals found in the generally higherfunctioning, lower service use, GPS sample; that is, the GPS DSM-IV PDD prevalence was 1.89% versus the GPS DSM-5 ASD prevalence of 1.46% (1.06-1.85%). Furthermore, this conclusion is supported by analyses indicating that the estimated prevalence of DSM-5 HPG ASD, 0.75% (0.58-0.93%), is virtually identical to the DSM-IV PDD prevalence in that same HPG population: 0.75% (0.57-0.92%).
Changes From DSM-IV PDD Diagnoses When DSM-5 ASD Criteria Are Applied This can be further divided into 3 important questions:
What happens to the children with DSM-IV Autistic Disorder (n ¼ 114) when DSM-5 criteria are applied? Answer: 99% (n ¼ 112) have DSM-5 ASD; 1% (n ¼ 2) have SCD. What happens to the children with DSM-IV Asperger disorder (n ¼ 34) when DSM-5 criteria are applied? Answer: 91% (n ¼ 31) have DSM-5 ASD; 6% (n ¼ 2) have SCD; 3% (n ¼ 1) have another psychiatric disorder. Finally, what happens to the children with DSM-IV PDD-NOS (n ¼ 58) when DSM-5 criteria are applied? Answer: 71% (n ¼ 41) have DSM-5 ASD; 22% (n ¼ 13) have SCD; 7% (n ¼ 4) have other, non-ASD or non-SCD disorders DSM-5 male and female ASD prevalence estimates are 3.16% (2.47-3.85%) and 1.17% (0.62-1.72%), respectively, indicating a sex ratio of 2.7:1.
Prevalence Estimates of SCD
We computed the estimated prevalence for SCD as 0.49% (0.21-0.77%). SCD cases were identified only in the GPS (0.49%); that is, there were no SCD cases coming from the HPG group. Indeed, the largest proportion of children with DSM-5 SCD was from those previously diagnosed with DSM-IV PDD-NOS (0.32% [0.09-0.54%]); very few of these children had been previously diagnosed with DSM-IV Asperger disorder (0.05% [9.00-0.13%]). Furthermore, male and female prevalence estimates for SCD were 0.56% (0.17-0.95%) and 0.42% (0.02-0.81%), respectively, with a sex ratio of 1.3:1.
Because DSM-5 ASD and SCD together seem to almost completely overlap with DSM-IV PDD, we attempted to examine how many children actually met criteria for a disorder characterized by clinically significant difficulties with social reciprocity. To do this, we combined the data for DSM-5 ASD and SCD to calculate the combined prevalence estimate. Using this strategy, it appears that the prevalence estimate for the DSM-IV PDD is almost identical to that of the combined DSM-5 ASD þ SCD (2.7%) for every category, including the total population, as well as the GPS, HPG, ASD subtypes, and sex (Table 1) .
Characteristics of Convergent/Divergent Cases of DSM-IV PDD and DSM-5 ASD Diagnoses Finally, we examined the characteristics of those children whose diagnoses found convergence between DSM-IV and DSM-5 and those whose diagnoses were divergent. Of 292 confirmative diagnostic assessment completers, 270 (92%) had convergent diagnoses by DSM-IV PDD and DSM-5 ASD criteria. That is, of these 292 screenpositive children, 63% (n ¼ 184) eventually had both DSM-IV PDD and DSM-5 ASD, thus indicating convergence between DSM-IV and DSM-5; another 29% (n ¼ 86) did not have either a final DSM-IV PDD or DSM-5 ASD diagnosis, meaning that they were also convergent but, in this instance, for no diagnosis. However, there were 22 cases (8%) for which the DSM-IV PDD and DSM-5 ASD diagnoses were divergent; that is, the DSM-IV PDD and the DSM-5 ASD diagnoses did not overlap. Based on this, one can conclude that 92% of individuals received similar diagnoses when both DSM-IV and DSM-5 criteria were applied. For the divergent cases, even though the PDD/ASD diagnoses did not overlap, all children still had a diagnosis of some form of developmental psychopathology. Of these 22 divergent cases, 17 (77%) moved from autistic disorder (n ¼ 2), Asperger disorder (n ¼ 2), and PDD-NOS (n ¼ 13) to DSM-5 SCD. In fact, all of the divergent DSM-IV autistic disorder cases moved to SCD, as did most of the Asperger and PDD-NOS cases. Ultimately, there were 5 case individuals who had a DSM-IV PDD diagnosis but did not meet criteria for either DSM-5 ASD or SCD. One was a child with DSM-IV Asperger disorder who met criteria for attentiondeficit/hyperactivity disorder (ADHD), as did 1 child with DSM-IV PDD-NOS. All of the remaining divergent PDD-NOS cases (n ¼ 3) met criteria for anxiety disorder. There were no age differences among the 3 groups; however, more boys were present in the ASD-convergent group, compared to the divergent group and the screen-positive children who ultimately were in the "no ASD" (nASD)-convergent groups (Table 2 ).
Significant differences in several aspects of ASD-related clinical characteristics emerged among the 3 groups (Table 3): ASSQ mean scores differed only between the no ASD-convergent and the ASD-convergent groups, with significantly higher scores in the ASD-convergent group. SRS total and subscale scores, except the motivation subscale in the ASD-convergent group, were significantly higher than those in the remaining 2 groups. When ADI-R and ADOS algorithm scores were examined, social reciprocity differed from each other on both the ADOS and ADI-R, with higher levels of impairment in the ASD-convergent group followed by the ASD-divergent group and then the no ASD-convergent group. In contrast, the ADI-R communication scores were significantly higher only in the ASD-convergent group when compared to the other 2 groups. ADOS communication scores differed in all 3 groups, with the most impairment in the ASD-convergent group followed by the ASDdivergent group and then the no ASDconvergent group. In addition, stereotypy scores were significantly higher only in the ASD-convergent group when compared to the other 2 groups, using both the ADOS and ADI-R. Analysis of variance (ANOVA) with Scheff e post hoc analyses was used to examine age differences among DIS, A-nASD, and A-ASD groups.
TABLE 2 Demographic Characteristics of DSM-IV Pervasive Developmental Disorder (PDD) -
Onset of symptoms differed among the 3 groups, with the earliest onset occurring in the ASDconvergent group, followed by ASD-divergent group and the no ASD-convergent group. Differences in imagination on the ADOS were observed only between the ASD-convergent and no ASD-convergent groups. Table 4 summarizes the BASC II-PRS mean T scores of 9 clinical subscales, externalizing and internalizing subscales, and 5 adaptive composite scores in the 3 groups. Of the clinical subscales, the anxiety score for the divergent group was significantly higher compared to that of the ASD-convergent group; however, there were no differences between the remaining groups. The withdrawal score was significantly higher in the ASD-convergent group when compared to the no ASD-convergent group; however, no differences were noted between the remaining groups. Likewise, on the BASC adaptive scales, social skills, leadership, and communication scores were significantly lower in the ASD convergent group when compared to the no ASD-convergent group.
Among the 17 discordant case individuals who moved from DSM-IV PDD to SCD, the reason appears to be primarily related to a relatively low level of RRBs. For the 5 discordant case individuals who had other forms of psychopathology, based on maternal reports, all had social and behavioral disruptions that appear to be associated with ADHD or anxiety disorder (Tables 3 and 4) .
DISCUSSION
Findings from this study show that the new DSM-5 ASD criteria yield changes in estimated prevalence previously established using the DSM-IV PDD criteria. These changes include an approximate 17% decrease in the ASD prevalence from the prior DSM-IV PDD prevalence estimate of 2.64% to a DSM-5 ASD prevalence of 2.20%. These findings are not surprising. When one examines the new DSM-5 criteria, it can be expected that some individuals without relatively high levels of the designated "core" ASD symptoms (social reciprocity and RRB) will move to 1 of 2 categories: no diagnosis or SCD. Furthermore, it might have been reasonable to expect that those at greatest risk for such shifting are those individuals primarily with significant language deficits, high overall levels of functioning, low levels to no RRB, and who barely meet DSM-IV PDD-NOS criteria.
In fact, the DSM-5 ASD criteria appear to offer meaningful clarifications relative to the previous diagnostic criteria, because almost all individuals with DSM-IV autistic disorder (98%) and Asperger disorder (92%) met DSM-5 ASD diagnostic criteria. 
Intellectual deficit** The majority of individuals (71%) with a DSM-IV PDD-NOS diagnosis have DSM-5 ASD, but a significant number (w29%) change. Such diagnostic changes occur exclusively among those individuals with a PDD-NOS diagnosis who were identified among the GPS, a group characterized by milder ASD symptoms, average intelligence, and less functional impairment. 4 In addition, these changes occurred evenly between boys and girls.
When reviewing profiles of the 22 case individuals with diagnostic shifts, we found that even though they were divergent on the basis of DSM-IV PDD and DSM-5 ASD diagnoses, all of these children still had a diagnosis of some form of developmental psychopathology. In fact, all of the divergent DSM-IV autistic disorder case subjects moved to SCD, as did most of the Asperger disorder and PDD-NOS case subjects (76%).
Among the 17 divergent case individuals who moved from DSM-IV PDD to SCD, the reason was primarily related to a relatively low level of RRBs, as seen in the ADOS and ADI-R stereotypy scores ( Table 3 ). The remaining 5 divergent case subjects had other forms of psychopathology, and also had lower SRS scores, higher BASC anxiety scores, and higher ADOS scores for overactivity and anxiety codes. Otherwise, they appeared similar to the other divergent case subjects with respect to demographics, cognitive level, ADOS and ADI-R algorithm scores, and parental ASSQ responses (data not shown). This suggests that for children who no longer met criteria for ASD or SCD, their social and behavioral disruptions were likely associated with ADHD or anxiety disorder; however, the sample size is too small for further meaningful statistical analyses.
We report that the estimated prevalence for SCD ¼ 0.49% in this community-ascertained population of school-aged children. Although most SCD cases came from previous DSM-IV PDD-NOS cases, we identified 3 new SCD case subjects (2 girls and 1 boy) who did not have a prior PDD diagnosis. All of these children had significant difficulties in communication accompanied Significant group differences (*p < .05; **p < .005).
e Analysis of variance with Scheff e post hoc analyses was performed to examine differences in associated clinical features between D-SCD, A-nASD and A-ASD groups (the D-other group was excluded from post hoc analyses because it had only 1 group member).
by a moderate lack of social reciprocity, based on both parental survey and direct interview; in addition, they all have modest difficulties in communication, as well as mild social reciprocity problems, based on the clinical interviews with the children.
In the final analysis, the divergence rate between DSM-IV PDD and DSM-5 ASD in the 292 screen-positive assessment completers is a modest but important 8%. Indeed, if one considers DSM-5 ASD and SCD to be in the same domain as DSM-IV PDD, then the divergence rate drops to a remarkable 2%. It appears that when diagnostic category reassignment occurs, it is the result of 2 principal factors: for those case individuals moving to SCD, it is due to relatively low levels of RRBs, whereas for those individuals ending up with other psychiatric diagnoses, it is that the symptoms of those disorders marginally interfere with structured social behavior. Most importantly, irrespective of the final diagnosis, all patients with a DSM-IV PDD diagnosis still had significant psychopathology that merited follow-up and treatment.
This study provides comprehensive prevalence estimates by applying validated, reliable, gold-standard screening procedures and diagnostic methods in a total population sample.
Study limitations include that the SCD screening was conducted using the ASSQ, a screening questionnaire designed for ASD. Because the sensitivity and specificity of the ASSQ for SCD is unknown, the SCD prevalence might have been underestimated in this study. Other limitations stem from missing data for non-participants and the relatively small proportion of children in the total sample who received a full diagnostic assessment. However, these are ubiquitous problems that are seen in similar epidemiological studies.
14 Various model-building analyses, previously reported, indicated that error introduced by "missingness" is minimal, 4 but we report ASD and SCD prevalence estimates with due caution about the risks of over-and underestimation.
In summary, our findings suggest that most individuals with a prior DSM-IV diagnosis of PDD move to the DSM-5 categories of ASD or SCD. In fact, fewer than 2% of DSM-IV PDD individuals had a DSM-5 diagnosis other than ASD or SCD. Indeed, the combined prevalence of DSM-5 ASD þ SCD is virtually identical to that of the DSM-IV PDD for every category. These data provide essentially no support for the concerns that individuals affected by DSM-IV PDD will "lose a diagnosis" with the advent of the DSM-5. When ASD and SCD are combined, then virtually everyone with a DSM-IV PDD remains on the "new spectrum." Because until proved otherwise, the treatments for ASD and SCD remain the same or similar, and it is important for children moving to SCD (and their families) to continue receiving the interventions that they received with the DSM-IV PDD diagnosis. In addition, those falling out of the DSM-5 ASD/ SCD group appear to have other significant and impairing disorders that are also important and certainly deserve the care and attention appropriate for those conditions; clinicians should promptly point these children in the right directions, even if ASD is not that direction. Finally, there is a need to follow up the DSM-IV-DSM-5-divergent children to understand the natural course and outcomes of their conditions and how they are related or not related to ASD. However, in the final analysis, whether the label is PDD, ASD, or SCD, extant diagnostic criteria are helpful in identifying a relatively large, clinically meaningful group of individuals and families who deserve comprehensive evaluations and evidencebased treatments as early as possible. &
Clinical Guidance
There has been concern that DSM-5 Autism Spectrum Disorder, including the end of the Autism, Asperger and PDD diagnoses, will have an impact on prevalence along with eligibility for services and force alterations of practice guidelines.
Hopefully allaying fears that DSM-5 creates major diagnostic changes for patients, this study found that the DSM-IV PDD and DSM-5 ASD prevalence are quite similar.
The present study indicates that more than 90% of individuals with a DSM-IV PDD diagnosis will have a DSM-5 ASD or SCD diagnosis.
Those who no longer meet ASD criteria came from DSM-IV PDD-NOS and still have significant developmental psychopathology.
For the practicing clinician, as well as for patients and their families, this study should provide reassurance that there can be a smooth transition from DSM-IV to DSM-5 criteria that offer more clarity in the ASD diagnosis while adding the new but related disorder, SCD, as part of a continuum of neurodevelopmental disorders.
